keyword
https://read.qxmd.com/read/24080749/clinical-activity-of-lenalidomide-in-visceral-human-immunodeficiency-virus-related-kaposi-sarcoma
#1
JOURNAL ARTICLE
Maud Steff, Véronique Joly, Julie Di Lucca, Judith Feldman, Samuel Burg, Laure Sarda-Mantel, Gilles Peytavin, Eduardo Marinho, Béatrice Crickx, Eric Raymond, Sylvie Lariven, Eve Maubec
IMPORTANCE: Curative treatment of aggressive Kaposi sarcoma (KS) with conventional chemotherapy in human immunodeficiency virus (HIV)-infected patients remains difficult. The administration of thalidomide, an immunomodulatory drug with antiangiogenic effects, is limited by its toxicity. This engenders interest in evaluating thalidomide analogues such as lenalidomide with better toxicity profiles. To our knowledge, we describe for the first time a patient with visceral KS successfully treated with lenalidomide...
November 2013: JAMA Dermatology
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.